Patents by Inventor Brian Sproat

Brian Sproat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220054524
    Abstract: The present invention relates to new nucleic acid molecules of therapeutic interest, in particular for use in the treatment of cancer.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 24, 2022
    Inventors: BRIAN SPROAT, CHRISTELLE ZANDANEL, FRANÇOISE BONO, ALEXANDRE SIMON
  • Patent number: 9896689
    Abstract: The present invention relates to a method of preparing triphosphate-modified oligonucleotides using a capture tag. The method allows the synthesis and purification of triphosphate-modified oligonucleotides in high yield and purity suitable for pharmaceutical applications.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: February 20, 2018
    Assignee: Rheinische Friedrich-Wilhelms-Universität Bonn
    Inventors: Janos Ludwig, Marion Goldeck, Brian Sproat
  • Publication number: 20170145410
    Abstract: The present invention relates to a method of preparing triphosphate-modified oligonucleotides using a capture tag. The method allows the synthesis and purification of triphosphate-modified oligonucleotides in high yield and purity suitable for pharmaceutical applications.
    Type: Application
    Filed: June 10, 2016
    Publication date: May 25, 2017
    Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAET BONN
    Inventors: Janos LUDWIG, Marion GOLDECK, Brian SPROAT
  • Publication number: 20160298116
    Abstract: The present invention relates to a method of preparing triphosphate-modified oligonucleotides using a capture tag. The method allows the synthesis and purification of triphosphate-modified oligonucleotides in high yield and purity suitable for pharmaceutical applications.
    Type: Application
    Filed: June 10, 2016
    Publication date: October 13, 2016
    Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAET BONN
    Inventors: Janos LUDWIG, Marion GOLDECK, Brian SPROAT
  • Patent number: 9399658
    Abstract: The present invention relates to a method of preparing triphosphate-modified oligonucleotides using a capture tag. The method allows the synthesis and purification of triphosphate-modified oligonucleotides in high yield and purity suitable for pharmaceutical applications.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: July 26, 2016
    Assignee: Rheinische Friedrich-Wilhelms-Universität Bonn
    Inventors: Janos Ludwig, Marion Goldeck, Brian Sproat
  • Publication number: 20140024819
    Abstract: The present invention relates to a method of preparing triphosphate-modified oligonucleotides using a capture tag. The method allows the synthesis and purification of triphosphate-modified oligonucleotides in high yield and purity suitable for pharmaceutical applications.
    Type: Application
    Filed: March 28, 2012
    Publication date: January 23, 2014
    Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAET BONN
    Inventors: Janos Ludwig, Marion Goldeck, Brian Sproat
  • Patent number: 5658731
    Abstract: Oligonucleotides having the general formula, ##STR1## in which B denotes an arbitrary nucleobase,A equals 0 or CH.sub.2 ;X or Z equals O, S, NH or denotes CH.sub.2 whereby X and Z can be the same or different,V and W denote O, S, Se, NH.sub.2 or an alkyloxy residue, or OH or SH whereby V and W can be the same or different in a monomer unit andL is a H atom or a partner of a binding pair andC equals --O--R and R is an alkyl group with at least 1 C atom which may be modified if desired, or it denotes an alkenyl or alkynyl group with at least 2 C atoms which may be modified if desired, whereby the modification consists of a substitution by one or several halogen, cyano, carboxy, hydroxy, nitro or/and mercapto residues, andn is an arbitrary whole number, are stable antisense probes which bind specifically. Such oligonucleotides and polynucleotides may be used for the regulation of gene expression and as pharmaceutical agents.
    Type: Grant
    Filed: January 23, 1995
    Date of Patent: August 19, 1997
    Assignee: Europaisches Laboratorium fur Molekularbiologie
    Inventors: Brian Sproat, Angus Lamond
  • Patent number: 5334711
    Abstract: A synthetic catalytic oligonucleotide structure and nucleotides having the general structural formula (I) contains: ##STR1## in which B represents a nucleoside base which is in particular selected from the group comprising adenin-9-yl (A), cytosin-1-yl (C), guanin-9-yl (G), uracil-1-yl (U), uracil-5-yl (.psi.), hypoxanthin-9-yl (I), thymin-1-yl (T) and 2-aminoadenin-9-yl,V in each nucleotide is independently an O or a CH.sub.2 group,X and W can in each nucleotide be the same or different and are independently of each other O, S, NH.sub.2, alkyl or alkoxy groups with 1 to 10, preferably with 1 to 4 carbon atoms,R is hydrogen or a straight-chained or branched alkyl, alkenyl or alkinyl group with 1 to 10 carbon atoms which is substituted, if desired, with halogen, cyano, isocyano, nitro, amino, carboxyl, hydroxyl or/and mercapto groups, and in which in at least one of the nucleotides the residue R in formula (I) is different from hydrogen and is suitable for the cleavage of a nucleic acid target sequence.
    Type: Grant
    Filed: June 22, 1992
    Date of Patent: August 2, 1994
    Assignee: Europaisches Laboratorium fur Molekularbiologie (EMBL)
    Inventors: Brian Sproat, Angus Lamond, Giovanni Paolella
  • Patent number: 5137698
    Abstract: An apparatus for carrying out chemical reaction sequences includes a stack of reaction plates arranged one above another and displaceable according to choice step by step in relation to one another, which are provided with passages arranged at the stepping interval, one of which passes in each case is formed as reaction chamber. A plate displacement device serves for the displacement of the respective plate, according to choice, in relation to the remaining plate stack. A pressure application part of a clamping device is provided with a faculty for movement of the plates in relation to one another between a pressure application position with sealing clamping together of the plates and a release position.
    Type: Grant
    Filed: January 22, 1990
    Date of Patent: August 11, 1992
    Assignee: Europaisches Laboratorium fur Molekularbiologic (EMBL)
    Inventors: Wilhelm Ansorge, Christian Schwager, Brian Sproat